Navigation Links
12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis
Date:8/19/2008

tions bronchiectasis and cystic fibrosis.

It is estimated that more than 600,000 in the major pharmaceutical markets suffer from bronchiectasis and Pharmaxis expects Bronchitol to be the first targeted medication for this patient group in 20 years, addressing an important medical need. Total U.S. medical care expenditure is US$13,000 per bronchiectasis patient, double that of patients without the disorder; and an increased overall cost to the US health system of US$630 million.

Forward-Looking Statements

The statements contained in this media release that are not purely historical are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements in this media release include statements regarding our expectations, beliefs, hopes, goals, intentions, initiatives or strategies, including statements regarding the potential for Aridol and/or Bronchitol. All forward-looking statements included in this media release are based upon information available to us as of the date hereof, and we assume no obligation to update any such forward-looking statement as a result of new information, future events or otherwise. We can not guarantee that any product candidate will receive FDA or other regulatory approval or that we will seek any such approval. Factors that could cause or contribute to such differences include, but are not limited to, factors discussed in the "Risk Factors and Other Uncertainties" section of our Form 20-F lodged with the U.S. Securities and Exchange Commission.

CONTACT:

Alan Robertson

Chief Executive Officer

Tel: +61-2-9454-7200

Email: alan.robertson@pharmaxis.com.au

RELEASED THROUGH:

Australia:

Virginia Nicholls

Tel: +61-417-610-824

Email: virginia.nicholls@pharmaxis.com.au
'/>"/>

SOURCE Pharmaxis Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
2. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
3. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
4. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
5. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
6. Vical Promotes Melanoma Awareness Month With Allovectin-7(R) Video Report
7. Update From Mipomersen Extended Dosing Study Continues to Show That Mipomersen Is Well Tolerated and Maintains Activity in Patients Treated for Up to 16 Months
8. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
9. Clinical Update - Decapeptyl(R)/Trelstar(R) 6-Month Formulation in Advanced Prostate Cancer
10. Phase III Data Published for Once Monthly Dose of Risedronate to Treat Postmenopausal Osteoporosis
11. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...f., Nov. 20 Epeius Biotechnologies... studies of Rexin-G in,chemotherapy-resistant met...presented by Dr. Sant P. Chawla, principal investi...ondon UK on November 13-15, 2008. Patients receive...d up to 9 months. Analysis of,safety and efficacy...
(Date:11/20/2008)...., Nov. 20 New Jersey American Wat...ory for its customers in the following municipalit... , Middlesex County , , , Dune...iscataway , South Plainfield , , ,...d Brook , Bridgewater , Green Brook ...
(Date:11/20/2008)...TOP LINE RESULTS OF FIRST PHASE III TRIAL SHOW SIG...IMPROVEMENT IN DAILY FUNCTION, IN, ...O, Calif., and BRUSSELS, Belgium, Nov. 20 /PRNewsw...daq: JAZZ ) and UCB (Euronext Brussels: UCB),an...s from the first of two,Phase III pivotal clinica...
(Date:11/20/2008)...., Nov. 20 Milk. It does a body go...ally thought. After years of,research, scientists...nd in,cow,s milk that stimulate the body,s own pr... Multimedia News Release, go to:, http://www.prnew...le developing new cancer therapies, the chief scie...
Breaking Medicine Technology:Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: Phase I/II & Confirmatory Phase II Studies 2New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2New Research on Genetic Changes in Melanomas and Teens Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 24662 1New Research on Genetic Changes in Melanomas and Teens Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 24662 2New Research on Genetic Changes in Melanomas and Teens Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 24662 3New Research on Genetic Changes in Melanomas and Teens Use of Indoor Tanning Could Lead to Better Prevention and Treatment Strategies 24662 4Back to School Resolution 3A Practice Food Safety and Healthier Eating 24656 1Back to School Resolution 3A Practice Food Safety and Healthier Eating 24656 2J P McCarthy Fund Grants 24250 000 to Karmanos Cancer Institute 24653 1J P McCarthy Fund Grants 24250 000 to Karmanos Cancer Institute 24653 2J P McCarthy Fund Grants 24250 000 to Karmanos Cancer Institute 24653 3J P McCarthy Fund Grants 24250 000 to Karmanos Cancer Institute 24653 4Possible Cause of Postpartum Depression Pinpointed 24649 1Possible Cause of Postpartum Depression Pinpointed 24649 2Possible Cause of Postpartum Depression Pinpointed 24649 3
...tivity and patient tolerance observed in Genotype,...ontinuous,delivery therapy, WASHINGTON, May 21, 20...privately held biopharmaceutical company, today an...hase 2 study comparing,the combination of injectab...ron alone in treatment-naive patients with genotyp...
...ESS WIRE)--May 21, 2007 - Results from a new,study...eek (DDW),conference, showed that more than 99 per...CV) infection who were treated,successfully with P...e virus up to seven years later - validating the u... according to study,authors. Currently, the best i...
Other Medicine Technology:Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference 2Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference 3Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference 4Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 2Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 3Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 4Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 5Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 6
(Date:11/22/2008)...Altering recipes to cut fat, salt a quick fix with...AY, Nov. 22 (HealthDay News) -- You can eat health...king good food choices, say experts with the Texas...an reduce the sugar, fat or salt content of almost...e in taste, nutrition specialist Mary Bielamowicz ...
(Date:11/21/2008)...Kids, parents and schools need to work together to...FRIDAY, Nov. 21 (HealthDay News) -- Behavior that ...ognized as bullying. , And as mounting research...the victim, mental-health professionals, schools, ...h new ways to combat this threatening behavior. ,...
(Date:11/21/2008)...LOVELAND, Colo., Nov. 21 ...ced it will present at the New York Society of,Se... Pharma Conference on,December 2, 2008 at 1177 Av...The presentation is scheduled to begin at 9:35 a.m... be available via live webcast and for two weeks,...
(Date:11/21/2008)...Finding might one day lead to a novel technique to...Y, Nov. 21 (HealthDay News) -- Belgian researchers... acid instead of sugar for food, and this might le...lls. , To survive and proliferate, all cells in...burning sugar [glucose], a process that requires o...
Breaking Medicine News(10 mins):Health News:Substitutions Make Holiday Fare Healthier 2Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:New Approach Keeps Tumor Cells From Refueling 2
...s to have struck the honeybee population across th...nty two states have been affected by this weird ai...bee keepers and honey production. Bee keepers hav...heir bee population. Sometime back, a parasite cal...
... of nanoparticle that could be used in tests for e... products, as well as for medical diagnosis. The r... Nanotechnology. Nanoparticles, according to Ian ...mechanical and aeronautical engineering and senior...
...tly increases a woman’s risk of becoming infected ...March 1st edition of The Journal of Infectious Dis...at several sexually transmitted infections increas...on of HIV. Although there are 173 million cases of...
...ave found a set of "master switches" that keep adu...te//. Unlocking the switches' code may one day ena...ant into patients with cancer and other bone marro...e control switches not at the gene level, but fart...
Other Medicine News:Health News:UC Davis Creates New Nanoparticles 2Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 2Health News:Vaginalis Increases the Risk of Becoming Infected With HIV 3Health News:Master Switches Found for Adult Blood Stem Cells 2
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: